Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Lumos Pharma Inc (LUMO)

Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Lumos Pharma Completes Successful Tender Offer and Merger with Double Point Ventures Quiver Quantitative, Inc. - Thu Dec 12, 2024

Lumos Pharma completed its merger with Double Point Ventures, acquiring a majority of shares through a tender offer.Quiver AI SummaryLumos Pharma, Inc. and Double Point Ventures LLC announced the completion...

LUMO : 4.34 (unch)
Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures’ Acquisition of Lumos Pharma GlobeNewswire - Thu Dec 12, 2024

LUMO : 4.34 (unch)
Lumos Pharma Presents New Data on LUM-201 from Phase 2 Trials for Pediatric Growth Hormone Deficiency at ESPE 2024 Quiver Quantitative, Inc. - Thu Nov 21, 2024

Lumos Pharma presented positive Phase 2 trial data for oral LUM-201, showing sustained growth in pediatric patients with hormone deficiency.Quiver AI SummaryLumos Pharma, Inc. has presented new analyses...

LUMO : 4.34 (unch)
Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201’s Unique Pulsatile Mechanism of Action GlobeNewswire - Thu Nov 21, 2024

LUMO : 4.34 (unch)
Lumos: Q3 Earnings Snapshot AP - Fri Nov 8, 2024

Lumos: Q3 Earnings Snapshot

LUMO : 4.34 (unch)
Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR) GlobeNewswire - Wed Oct 23, 2024

LUMO : 4.34 (unch)
Lumos: Q2 Earnings Snapshot AP - Thu Aug 1, 2024

Lumos: Q2 Earnings Snapshot

LUMO : 4.34 (unch)

Barchart Exclusives

Nike Stock Sinks to Multi-Year Lows: There’s No Quick Fix for NKE Here Barchart - 15 minutes ago
Nike stock recently fell to a 12-year low and has lost almost $200 billion in market cap from the November 2021 highs. While not a real bargain yet, the stock has started to look attractive at these levels. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.